Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis
The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The diagnosis and treatment of invasive pulmonary aspergillosis (IPA) are ongoing challenges in clinical practice. While important advances have recently been made, including enhanced diagnostic modalities as well as novel therapeutic and prophylactic options, more effective options are urgently needed as the population of immunocompromised patients continues to expand. Areas covered: In this paper, we review novel approaches to diagnosis of IPA, including multiplex PCR, Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry and provide a detailed review of the extended-spectrum triazole isavuconazole, which was approved in 2015 to treat IPA. Expert commentary: We explore burgeoning approaches to diagnosis, including the lateral flow assay, volatile organic compounds, and artificial olfactory technology, as well as novel antifungal agents to treat IPA such as SCY-078 and F901318.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In these patients, with impaired immune function, Aspergillus growth in the lung leads to tissue destruction, angio-invasion, a septic state in its final phase and sometimes haemoptysis [98].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [98]
Citations
Cites
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926 · cited 3×
“with prolonged neutropenia, HSCT, SOT, or T-cell deficiencies [7,8].”
BackgroundSelf-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706 · cited 2×
“a high index of suspicion for early diagnosis [8].”
BackgroundSelf-citationElectronic Nose: Current Status and Future Trends
Röck, F., Barsan, N., & Weimar, U. (2008) · Chemical Reviews · doi:10.1021/cr068121q · Cited by 1,437 · cited 1×
“inexpensive and noninvasive method to diagnose IPA [124].”
MethodLenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Attal, M., Lauwers-Cances, V., Hulin, C., Leleu, X., Caillot, D., Escoffre, M., Arnulf, B., Macro, M., Belhadj, K., Garderet, L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611750 · Cited by 1,257
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Denning, D. W., Cadranel, J., Beigelman-Aubry, C., Ader, F., Chakrabarti, A., Blot, S., Ullmann, A. J., Dimopoulos, G., & Lange, C. (2016) · European Respiratory Journal · doi:10.1183/13993003.00583-2015 · Cited by 1,030 · cited 1×
“Chronic pulmonary aspergillosis represents a different form of pulmonary disease and includes conditions such as chronic cavitary pulmonary aspergillosis, chronic fibrosing pulmonary aspergillosis, Aspergillus nodule, simple aspergilloma, and tracheobronchial aspergillosis [3,19].”
BackgroundMaertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01159-9 · Cited by 1,001 · cited 2×
“Successful outcomes have been reported for patients with IA and renal impairment [90].”
BackgroundThe clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 727
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Marty, F. M., Ostrosky-Zeichner, L., Cornely, O. A., Mullane, K. M., Perfect, J. R., Thompson, G. R., Alangaden, G. J., Brown, J. M., Fredricks, D. N., Heinz, W. J., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00071-2 · Cited by 704 · cited 1×
“In addition to this, isavuconazole has been evaluated in a randomized, double-blind noninferiority trial for the treatment of IA and, in a separate, open-label study in the treatment of mucormycosis [90,91].”
Tissot, F., Agrawal, S., Pagano, L., Petrikkos, G., Groll, A. H., Skiada, A., Lass-Flörl, C., Calandra, T., Viscoli, C., & Herbrecht, R. (2017) · Haematologica · doi:10.3324/haematol.2016.152900 · Cited by 682
Research works printed but not linked: 14
- Jaumally BA, 2017, Respir Med Case Rep, 20, 156
- Agarwal R, 2016, Med Mycol, 87
- Fernandes L, 2016, J Clin Diagn Res, 10, OD16
- Machetti M, 2006, Infez Med, 14, 197
- Walsh TJ, 1998, Curr Clin Top Infect Dis, 18, 101
- Cruciani M, 2015, Cochrane Database Syst Rev, 10, CD009551
- Donnelley MA, 2016, Infect Drug Resist, 9, 79
- Desai A, 2016, Clin Pharmacol Drug Dev, 9, 291
- Law D, 2016, The efficacy of F901318 a novel antifungal drug in an animal model of aspergillosis
- Arthurs B, 2017, Respir Med Case Rep, 21, 27
- Er Dedekarginoglu B, 2017, Exp Clin Transplant, 15, 214
- Hollomon D, 2017, Pest Manag Sci, 12, 412
- Astvad KM, 2017, Clin Microbiol Infect, 32, 311
- 10.1128/AAC.02068-16 · DOI
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“In these patients, with impaired immune function, Aspergillus growth in the lung leads to tissue destruction, angio-invasion, a septic state in its final phase and sometimes haemoptysis [98].”
BackgroundInvasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices
Gaffney, S. M., Kelly, D., Rameli, P. M., Kelleher, E. M., & Martín‐Loeches, I. (2023) · Apmis · doi:10.1111/apm.13316 · Cited by 51
“The clinical presentation is relatively rapid, ranging from days to weeks (16).”
BackgroundUnderstanding the environmental drivers of clinical azole resistance in Aspergillus species
Sen, P., Vijay, M., Singh, S., Hameed, S., & Vijayaraghavan, P. (2022) · Drug Target Insights · doi:10.33393/dti.2022.2476 · Cited by 40
“Invasion of the lungs by Aspergillus leads to tissue damage leading to sepsis and sometimes haemoptysis in later stages (11).”
BackgroundCarbohydrate Specificity of Antibodies against Phytopathogenic Fungi of the Aspergillus Genus
Krylov, V. B., Петрук, М. И., Глушко, Н. И., Khaldeeva, E. V., Мокеева, В. Л., Биланенко, Е. Н., Lebedin, Y. S., Еремин, С. А., & Nifantiev, N. E. (2018) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683818050095 · Cited by 10
Corrêa-Almeida, C., Borba-Santos, L. P., Rollin‐Pinheiro, R., Barreto‐Bergter, E., Rozental, S., & Kurtenbach, E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.795255 · Cited by 8
Metadata
- Authors
- McCarthy, M. W., & Walsh, T. J.
- Affiliations
- Cornell University (US)
- Weill Cornell Medical Center (US)
- Corresponding author
- McCarthy, Matthew William
- Venue
- Expert Review of Respiratory Medicine
- Publisher
- Informa UK Limited
- Published
- 2017-06-21
- Volume
- 11
- Issue
- 9
- Pages
- 739-748
- ISSN
- 1747-6348 (ISSN-L)
- 1747-6356
- OpenAlex
- W2623020088
- Cited by
- 8
- References
- 137
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 4 · 2018: 1 · 2017: 1
- FWCI
- 0.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Respiratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- invasive pulmonary aspergillosis, Aspergillus, immunocompromised patients, diagnostic methods, multiplex PCR, MALDI-TOF mass spectrometry, isavuconazole, triazoles, lateral flow assay, volatile organic compounds, antifungal agents, prophylaxis
- MeSH terms
- Antifungal Agents, Humans, Nitriles, Pyridines, Triazoles, Immunocompromised Host, Treatment Outcome, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Invasive Pulmonary Aspergillosis, Multiplex Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis. https://app.cochat.ai/papers/10.1080/17476348.2017.1340835
- The paper
- McCarthy, M. W., & Walsh, T. J. (2017). Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis. Expert Review of Respiratory Medicine. https://doi.org/10.1080/17476348.2017.1340835
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.